Prozomix and ginkgo bioworks collaborate on next-gen enzyme development for sustainable api manufacturing

The partnership combines ginkgo's ai/ml and enzyme engineering expertise with prozomix's wealth of enzyme sequence data to create best-in-class enzymes for api manufacturing northumberland, england and boston , april 3, 2024 /prnewswire/ -- prozomix, a uk-based biotech company focused on novel biocatalyst discovery and manufacturing, and ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. together, ginkgo and prozomix aim to build out the production of next generation enzyme plates for active pharmaceutical ingredient (api) manufacturing.
DNA Ratings Summary
DNA Quant Ranking